Details for New Drug Application (NDA): 062716
✉ Email this page to a colleague
NDA 062716 describes VANCOCIN HYDROCHLORIDE, which is a drug marketed by Ani Pharms and Steriscience Speclts and is included in six NDAs. It is available from two suppliers. Additional details are available on the VANCOCIN HYDROCHLORIDE profile page.
The generic ingredient in VANCOCIN HYDROCHLORIDE is vancomycin hydrochloride. There are twenty-two drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.
The generic ingredient in VANCOCIN HYDROCHLORIDE is vancomycin hydrochloride. There are twenty-two drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.
Summary for 062716
| Tradename: | VANCOCIN HYDROCHLORIDE |
| Applicant: | Steriscience Speclts |
| Ingredient: | vancomycin hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062716
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
| Approval Date: | Mar 13, 1987 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Mar 13, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
